We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-9.64%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$585M
AUM Growth
-$73.1M
Cap. Flow
+$1.63M
Cap. Flow %
0.28%
Top 10 Hldgs %
31.26%
Holding
141
New
43
Increased
25
Reduced
14
Closed
51

Top Buys

Rank Stock Value
1
GRFS
Grifois
GRFS
+$10.6M
2
XENT
Intersect ENT, Inc
XENT
+$6.54M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.92M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.92M
5
ESTA icon
Establishment Labs
ESTA
+$5.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$10.1M
2
DHR icon
Danaher
DHR
+$7.15M
3
ARQL
Arqule Inc
ARQL
+$6.98M
4
GH icon
Guardant Health
GH
+$6.04M
5
ABBV icon
AbbVie
ABBV
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 39.74%
2 Industrials 1.15%
3 Consumer Staples 0.71%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$22.5M 3.85%
+250,000
New +$22.8M
INSP icon
2
Inspire Medical Systems
INSP
$1.5B
$21.8M 3.73%
357,700
-42,300
-11% -$2.79M
AMGN icon
3
CALL
Amgen
AMGN
$204B
$19.4M 3.31%
+100,000
New +$19.2M
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$18.9M 3.23%
125,000
-95,000
-43% -$14.5M
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
$18.9M 3.22%
873,800
+152,885
+21% +$4.06M
FXH icon
6
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$18.5M 3.16%
250,000
+50,000
+25% +$3.81M
INSP icon
7
CALL
Inspire Medical Systems
INSP
$1.5B
$16.8M 2.87%
275,000
+175,000
+175% +$11.5M
ZBH icon
8
Zimmer Biomet
ZBH
$18.8B
$16.1M 2.75%
120,965
-43,835
-27% -$5.66M
NSTG
9
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$15.3M 2.62%
710,000
+465,000
+190% +$12.3M
ICUI icon
10
ICU Medical
ICUI
$4.32B
$14.8M 2.52%
92,500
+13,381
+17% +$2.66M
MJ icon
11
PUT
Amplify Alternative Harvest ETF
MJ
$104M
$14.5M 2.48%
58,333
+22,916
+65% +$7.39M
ESTA icon
12
Establishment Labs
ESTA
$2.73B
$14.1M 2.41%
745,163
+255,673
+52% +$5.5M
REGN icon
13
CALL
Regeneron Pharmaceuticals
REGN
$78.2B
$13.9M 2.37%
+50,000
New +$14.8M
ZBH icon
14
CALL
Zimmer Biomet
ZBH
$18.8B
$13.7M 2.34%
+103,000
New +$13.3M
XENT
15
CALL
DELISTED
Intersect ENT, Inc
XENT
$13.2M 2.25%
775,000
+575,000
+288% +$10.5M
STAA icon
16
STAAR Surgical
STAA
$1.21B
$13M 2.22%
504,012
-34,588
-6% -$1.05M
SNN icon
17
CALL
Smith & Nephew
SNN
$13.5B
$12.8M 2.18%
265,000
+115,000
+77% +$5.29M
BHVN
18
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12.5M 2.14%
300,000
– –
XBI icon
19
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$11.4M 1.95%
+150,000
New +$12.5M
XENT
20
DELISTED
Intersect ENT, Inc
XENT
$11.4M 1.95%
670,000
+359,174
+116% +$6.54M
AGN
21
DELISTED
Allergan plc
AGN
$11.3M 1.93%
67,109
+20,000
+42% +$3.26M
WAT icon
22
CALL
Waters Corp
WAT
$36.8B
$11.2M 1.91%
+50,000
New +$10.8M
REGN icon
23
Regeneron Pharmaceuticals
REGN
$78.2B
$11.1M 1.9%
40,000
+20,000
+100% +$5.92M
IBB icon
24
CALL
iShares Biotechnology ETF
IBB
$9.18B
$10.9M 1.86%
+109,200
New +$11.4M
GRFS
25
Grifois
GRFS
$5.35B
$9.94M 1.7%
+496,201
New +$10.6M
1
2 3 4 5

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
SR
Swiss Re Zurich, Switzerland $16.4M AUM
TC
TradeLink Capital Chicago, Illinois $13.2M AUM 33.27% 1-Year Est. Return

Pura Vida Investments's Q3 2019 Portfolio in Review

As of Q3 2019, Pura Vida Investments held 141 positions worth $585M, down 11% from $658M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2019 filing shows 43 new, 25 increased, 14 reduced and 51 closed positions. Its largest new stake was Grifois: 496,201 shares worth $9.94M. The largest sale was Boston Scientific, an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 45% a quarter earlier, followed by Industrials and Consumer Staples.

  • Pura Vida Investments's largest Q3 2019 buy was Grifois: 496,201 shares worth $9.94M.
  • Pura Vida Investments added most to Intersect ENT, Inc in Q3 2019, an estimated $6.54M increase.
  • Pura Vida Investments's biggest Q3 2019 reduction was Zimmer Biomet, cutting an estimated $5.66M.
  • Pura Vida Investments fully exited Boston Scientific in Q3 2019, selling an estimated $10.1M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $585M portfolio in Q3 2019.
  • Pura Vida Investments opened 43 new positions and closed 51 in Q3 2019.
  • Pura Vida Investments's portfolio value fell 11% quarter-over-quarter to $585M.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.